Mann Eye Institute and Laser Center

What Mann Eye Institute and Laser Center does

Mann Eye Institute and Laser Center is a private, veteran-owned ophthalmology and optometry practice founded in 1977 by Dr. Paul Michael Mann and headquartered in Houston, Texas. The practice operates 16 clinic locations spanning the greater Houston and Austin metropolitan areas, supported by ambulatory surgery centers (Mann Cataract Surgery Center, Grand Parkway Surgery Center) and an office-based surgery center in North Austin. It employs 101–250 staff, including board-certified ophthalmologists, therapeutic optometrists, and subspecialty fellows covering cornea, retina, glaucoma, and oculoplastic surgery. Its core surgical offering centers on NextLevel LASIK using the Alcon WaveLight Plus platform (first in Texas, third in U.S.) and laser cataract surgery via the Catalys femtosecond laser paired with premium Active Life intraocular lenses; supplementary services include EVO ICL implantation, refractive lens exchange, MIGS glaucoma procedures, corneal crosslinking, LumiThera Valeda photobiomodulation for dry AMD, oculoplastic and cosmetic surgery, dry eye management, myopia management, and routine optical services.

The practice generates revenue through four primary streams: (1) one-time surgical fees for LASIK, cataract surgery with premium IOLs, and other refractive procedures priced on bundled, transparent packages ($1,800–$4,000 per eye for LASIK, with premiums for advanced technology and lens upgrades); (2) one-time optical product sales (prescription eyewear, specialty contact lenses) across all 16 locations; (3) recurring clinical revenue from comprehensive eye exams and chronic disease management billed through insurance networks; and (4) transaction fees from third-party financing partners (CareCredit, Affirm, Alphaeon Credit) that facilitate higher elective procedure conversion. Its go-to-market combines direct-to-consumer demand generation (free LASIK self-tests, online scheduling, transparent pricing) with a long-running optometric co-management referral program dating to the early 1980s and broad medical/vision insurance network participation across both Texas metros.

The company is differentiated by early-adopter technology positioning (WaveLight Plus, Catalys, Contoura topography, Valeda), documented outcomes (96% of LASIK patients achieving 20/20 or better; 100% of TECNIS Odyssey study patients at 20/25 or better; 5.0/5.0 average rating from ~15,500 reviews), and decades of founder-level surgical experience (Dr. Mike Mann: 40,000+ LASIK / 50,000+ cataract surgeries; Dr. Paul Mann: 50,000+ refractive procedures). It remains founder/family-owned with no evidence of external private equity, no public listing, and no disclosed M&A activity.

Name

Mann Eye Institute and Laser Center

Legal name

Mann Eye Institute and Laser Center

Website

https://manneye.com

Company type

Private

Founded year

1977

Operating status

Operating

Headcount range

101–250 employees

Short description

Mann Eye Institute and Laser Center is a private, multi-location ophthalmology and optometry practice operating 16 clinics across greater Houston and Austin, Texas, providing LASIK, laser cataract surgery, premium IOLs, retina, glaucoma, oculoplastics, and general eye care to consumer patients of all ages.

Ownership category

akta.pro rank

Product category

Ophthalmology and Refractive Surgery Services

NAICS

Offices of Optometrists (62132), Optical Goods Retailers (456130)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Ophthalmic Goods (3851)

akta.pro primary industry

Cornea, External Disease & Refractive Surgery (LASIK/PRK) (HLAKAKAF)

akta.pro secondary industries

Ophthalmology Surgery Centers (HLAFAIAF), Comprehensive Eye Exams & Vision Care (HLAKAKAA), Contact Lens Specialty & Myopia Control (HLAKAKAK)

Keywords

• Refractive eye surgery
• LASIK eye surgery
• Cataract surgery services
• Ophthalmology clinic network
• Premium lens implants

Headquarters

HQ city

Houston

HQ country

United States

HQ region

North America

Offices17 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain, Others

Revenue model

1. Surgical Vision Correction Procedures: One-time surgical procedures including Advanced/NextLevel LASIK, laser cataract surgery with premium IOLs, EVO ICL implantation, refractive lens exchange, and corneal crosslinking. Revenue generated per procedure with bundled pricing covering pre-op evaluation, the procedure, and post-operative follow-up visits. Enhancement policies are defined within the bundled price.
2. Optical Products (Glasses and Contacts): Sale of prescription eyewear, contact lenses including specialty scleral and keratoconus lenses, and related optical products across all 16 locations with on-site optical shops.
3. Comprehensive Eye Exams and Medical Eye Care: Billable clinical visits including annual dilated eye exams, medical disease management (glaucoma, diabetic retinopathy, macular degeneration, dry eye, cornea conditions), and diagnostic imaging services. Revenue from insurance reimbursements and patient payments.
4. Financing and Payment Plan Services: Partnership with third-party financing providers (CareCredit, Affirm, Alphaeon Credit) and guaranteed-approval financing programs generates revenue through patient financing arrangements and facilitates higher procedure conversion rates.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Mann Eye Institute and Laser Center operates a 16-location ophthalmology and optometry practice delivering the full continuum of eye care, from routine exams and prescription eyewear to advanced surgical vision correction. Its flagship offerings are all-laser LASIK (NextLevel LASIK on the Alcon WaveLight Plus platform), femtosecond laser cataract surgery with premium Active Life lens implants, EVO ICL implantation, refractive lens exchange, and subspecialty care for cornea, glaucoma, retina, dry eye, oculoplastics, and pediatric myopia.

Product overview

Mann Eye Institute and Laser Center is a multi-location ophthalmology and optometry practice offering a unified, full-spectrum eye care platform spanning 16 locations in the Houston and Austin metro areas of Texas. The core offering centers on surgical and medical eye care, anchored by NextLevel LASIK (powered by the Alcon WaveLight Plus system), laser cataract surgery (using the Catalys femtosecond laser with premium Active Life lens implants), EVO ICL implantation for high refractive error patients, and Refractive Lens Exchange. These surgical flagship offerings are complemented by subspecialty modules including corneal crosslinking for keratoconus, MIGS procedures for glaucoma, Valeda light therapy for dry AMD, dry eye treatment programs, oculoplastic and cosmetic surgery, retina disease management, and myopia management. The practice also provides comprehensive primary eye care and optical services (glasses, contacts, specialty lenses) across all locations, creating a vertically integrated continuum from routine exams through complex surgical procedures. The platform is distinguished by early adoption of advanced laser and diagnostic technologies, a team of board-certified ophthalmologists and therapeutic optometrists with subspecialty expertise, and documented outcomes reporting including 100% of NextLevel LASIK patients achieving 20/20 or better vision.

Differentiator

Problem solved

Functional benefit

Products and services

• NextLevel LASIK (WaveLight Plus) Advanced all-laser LASIK procedure using the Alcon WaveLight Plus platform with integrated diagnostics, topography-guided treatment, FS200 femtosecond laser flap creation, and customized excimer ablation profiles for personalized vision correction. Targeted at adults seeking to reduce or eliminate dependence on glasses and contacts.
• Laser Cataract Surgery (Catalys Femtosecond Laser) Femtosecond laser-assisted cataract surgery using the Catalys laser system for precision lens fragmentation, astigmatism management, and premium Active Life lens implantation to restore clear vision and reduce dependence on glasses. Targeted at cataract patients, often older adults.
• EVO ICL (Implantable Collamer Lens) Implantable Collamer Lens procedure involving surgical insertion of a biocompatible artificial lens to correct refractive errors in patients with high myopia or those who are poor LASIK candidates.
• Refractive Lens Exchange Customizable vision correction procedure involving surgical replacement of the eye's natural lens with an artificial lens implant, aimed at reducing dependency on glasses and contacts for presbyopic and over-40 patients.
• Corneal Crosslinking Corneal collagen crosslinking procedure designed to strengthen corneal tissue and halt progression of keratoconus and post-surgical corneal instability.
• Minimally Invasive Glaucoma Surgery (MIGS) Minimally invasive glaucoma surgical procedures including iStent implantation, goniotomy, and ab-interno canaloplasty to lower intraocular pressure by unclogging or enhancing the eye's natural drainage system.
• Valeda Light Therapy (LumiThera Dry AMD Treatment) FDA-authorized photobiomodulation treatment for dry age-related macular degeneration using the LumiThera Valeda Light Delivery System, integrated into the practice's comprehensive retina care program.
• Dry Eye Treatment Comprehensive dry eye diagnosis and management program using advanced diagnostics and targeted treatment plans, including MYE Drop therapy and interventional in-office treatments.
• Oculoplastic and Cosmetic Surgery Surgical and non-surgical facial cosmetic and reconstructive procedures including eyelid lifts (blepharoplasty), brow lifts, facelifts, Botox, dermal fillers, CO2 laser treatments, and orbital surgery performed by oculoplastic specialists.
• General Eye Care and Optical Services Comprehensive dilated eye examinations, ocular health evaluation, prescription glasses and contact lenses including specialty scleral and keratoconus lenses, and pediatric through geriatric primary eye care across all 16 locations.
• Retina Disease Management Medical and surgical management of retinal conditions including diabetic retinopathy, macular degeneration, retinal vascular disease, retinal detachments, macular holes, and inherited retinal diseases.
• Myopia Management Pediatric myopia management program integrating specialty contact lenses, lifestyle and monitoring protocols, and ongoing assessment to slow progression of nearsightedness in children and young adults.
• Glaucoma Management Comprehensive glaucoma diagnosis and management including medical therapy, laser procedures, and MIGS surgery, with emphasis on early detection to prevent vision loss.
• Active Life Premium Lens Implants Premium intraocular lens implants (multifocal, trifocal, and toric variants) tailored to patient lifestyle needs and visual goals, bundled with laser cataract surgery and post-operative care to reduce dependence on glasses and contacts after surgery.

Quantifiable outcome

• 96% of LASIK patients achieve 20/20 or better vision; over half reach 20/12 vision; 96.3% report being 'completely satisfied'; 99.1% would recommend the procedure
• +2 more outcomes

Named customers6 records

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Five partnerships are on record, tiered core.

• Johnson & Johnson Vision (TECNIS Odyssey)coreTechnology or Integration · 9 February 2026Mann Eye Institute published clinical research in Clinical Ophthalmology evaluating visual outcomes with Johnson & Johnson Vision's TECNIS Odyssey intraocular lens in bilateral cataract surgery. The study found 100% of patients achieved 20/25 or better vision at distance, demonstrating the institute's adoption of advanced lens technology from J&J Vision.
• Alcon (WaveLight Plus, FS200)coreTechnology or IntegrationMann Eye Institute was the first in Texas and third in the U.S. to deploy the Alcon WaveLight Plus NextLevel LASIK platform, incorporating the FS200 femtosecond laser for all-laser flap creation. Alcon's advanced excimer and femtosecond laser systems form the core technology platform for the practice's primary surgical offering.
• CareCreditcoreChannel Partner/ Reseller/ DistributorCareCredit healthcare financing card offered as one of three primary patient financing options, enabling patients to pay for LASIK and other procedures through installment plans.
• AffirmcoreChannel Partner/ Reseller/ DistributorAffirm installment financing offered as a patient payment option for LASIK, cataract surgery, and other procedures with transparent, fee-free or low-interest payment plans.
• Alphaeon CreditcoreChannel Partner/ Reseller/ DistributorAlphaeon Credit (now a division of Bancorp Bank) offered as a third patient financing option, specializing in healthcare and lifestyle procedures to make elective eye surgery more financially accessible.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Houston Eye Associates: Large multi-specialty ophthalmology group with multiple locations across the Houston metro offering cataract surgery, glaucoma, retina, cornea, and oculoplastic services. Closely comparable in scale, subspecialty breadth, and regional geography to Mann Eye Institute.
• TLC Laser Eye Centers: National LASIK provider with multiple U.S. locations offering laser vision correction. Direct competitor in the LASIK category with similar premium-tier positioning and consumer financing arrangements.
• LasikPlus: National LASIK-focused chain with multiple locations offering laser vision correction at transparent bundled pricing. Direct competitor in LASIK volume and consumer-facing marketing, with overlapping Alcon/AMO platform adoption.
• Berkeley Eye Center: Houston-based multi-location ophthalmology and optometry practice founded in 1959 offering LASIK, cataract surgery, optical services, and comprehensive eye care across the greater Houston metro. Most directly comparable peer given overlapping Houston geography, similar multi-clinic model, and competing LASIK/cataract surgical offering.
• Whitsett Vision Group: Houston-based multi-location ophthalmology practice offering LASIK, cataract surgery, and comprehensive eye care in the same Houston metro as Mann Eye. Closely comparable peer competing for surgical volume, premium IOL patients, and referring providers.

Broad incumbents

• EyeCare Partners: PE-backed national ophthalmology and optometry platform (backed by Partners Group) operating hundreds of locations across the U.S. Competes for surgeon talent, M&A targets, and premium IOL/laser contracts in the same provider space as Mann Eye, with substantially more capital and geographic reach.
• US Eye: PE-backed (Cressey & Company) multi-specialty ophthalmology platform with 60+ locations across the southeastern U.S., offering LASIK, cataract surgery, oculoplastics, and retina services. Comparable business model of consolidating regional ophthalmology practices under a single brand with integrated ASCs.

Regional players

• Hoopes Vision: Utah-based premium LASIK and cataract surgery practice founded by Dr. Phillip Hoopes, Sr., and operated with multiple surgeons across the Salt Lake City metro. Comparable independent multi-location refractive and cataract practice model with early-adopter technology positioning, though in a different geography.
• Assil Eye Institute: Los Angeles-based multi-subspecialty ophthalmology practice offering LASIK, cataract surgery, and oculoplastic services. Comparable premium-tier independent practice model with early adopter technology positioning, but operating in a different geography.
• IQ Laser Vision: California-based LASIK and cataract surgery practice with multiple locations in the Los Angeles and San Gabriel Valley metros. Comparable premium-tier refractive surgery practice model with transparent bundled pricing and consumer financing, though West Coast focused.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks2 records

Key highlights7 records

Customer concentration

• Xx.com/manneyeinst
• YouTubeyoutube.com/user/MannEyeInstitute
• Facebookfacebook.com/manneyeinstitute
• Instagraminstagram.com/manneyeinst
• LinkedInlinkedin.com/company/mann-eye-institute-and-laser-center

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mann Eye Institute and Laser Center